{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:17:05Z","timestamp":1786997825384,"version":"build-2736575974"},"reference-count":69,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,1,1]],"date-time":"2009-01-01T00:00:00Z","timestamp":1230768000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2009,1]]},"DOI":"10.1016\/j.vaccine.2008.10.044","type":"journal-article","created":{"date-parts":[[2008,11,11]],"date-time":"2008-11-11T02:54:04Z","timestamp":1226372044000},"page":"290-297","source":"Crossref","is-referenced-by-count":23,"title":["Adverse events after anthrax vaccination reported to the Vaccine Adverse Event Reporting System (VAERS), 1990\u20132007"],"prefix":"10.1016","volume":"27","author":[{"given":"Manette T.","family":"Niu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ball","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily Jane","family":"Woo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dale R.","family":"Burwen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen","family":"Knippen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Miles","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2008.10.044_bib1","series-title":"The anthrax vaccine: is it safe? Does it work?","year":"2002"},{"key":"10.1016\/j.vaccine.2008.10.044_bib2","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1002\/pds.712","article-title":"Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"11","author":"Sever","year":"2002","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2008.10.044_bib3","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1002\/pds.936","article-title":"Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)","volume":"13","author":"Sever","year":"2004","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2008.10.044_bib4","unstructured":"Review of VAERS Anthrax vaccine reports received through 8\/15\/05, and adverse event reports submitted to Docket No. 1980N-0208, December 13, 2005, FDA Weblink: http:\/\/www.fda.gov\/ohrms\/dockets\/dockets\/80n0208\/80n-0208-bkg0006-19-Ref-17-VAERS-Vol225.pdf (Reference 17)."},{"key":"10.1016\/j.vaccine.2008.10.044_bib5","unstructured":"Centers for Disease Control and Prevention. Use of anthrax vaccine in response to terrorism: supplemental recommendations of the Advisory Committee on Immunization Practices. Morb Mort Wkly Rep 2002;51(45):1024\u20136."},{"key":"10.1016\/j.vaccine.2008.10.044_bib6","unstructured":"Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices. Clin Toxicol 2001;39(1):85\u2013100."},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib7","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2105\/AJPH.2004.038349","article-title":"In their own words: lessons learned from those exposed to Anthrax","volume":"95","author":"Blanchard","year":"2005","journal-title":"Am J Public Health"},{"issue":"16","key":"10.1016\/j.vaccine.2008.10.044_bib8","doi-asserted-by":"crossref","first-page":"3109","DOI":"10.1016\/j.vaccine.2006.01.043","article-title":"UK armed forces responses to an informed consent policy for anthrax vaccination: a paradoxical effect?","volume":"24","author":"Murphy","year":"2006","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib9","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1016\/j.vaccine.2004.03.068","article-title":"Media coverage of anthrax vaccination refusal by Australian Defense Force Personnel","volume":"23","author":"Ackermann","year":"2004","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.044_bib10","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1002\/pds.1302","article-title":"Factors influencing laboratory workers\u2019 decisions to accept or decline anthrax vaccine adsorbed (AVA): results of a decision-making study in CDC\u2019s anthrax vaccination program","volume":"15","author":"Fowler","year":"2006","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2008.10.044_bib11","unstructured":"Gillis J. No Hope for stockpile of new Anthrax vaccine by November. The Washington Post; March 17, 2006. p. A01."},{"key":"10.1016\/j.vaccine.2008.10.044_bib12","unstructured":"Bioport Corporation. Anthrax Vaccine Adsorbed (Biothrax TM), Package Insert; 2002."},{"key":"10.1016\/j.vaccine.2008.10.044_bib13","doi-asserted-by":"crossref","first-page":"632","DOI":"10.2105\/AJPH.52.4.632","article-title":"Field evaluation of a human anthrax vaccine","volume":"56","author":"Brachman","year":"1962","journal-title":"Am J Public Health"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.044_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.4049\/jimmunol.73.6.387","article-title":"Studies on immunity in anthrax: V. Immunizing activity of alum-precipitated protective antigen","volume":"73","author":"Wright","year":"1954","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2008.10.044_bib15","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0264-410X(01)00387-5","article-title":"Anthrax vaccine: short-term safety experience in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.044_bib16","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1002\/pds.1213","article-title":"Development of the Vaccine Analytic Unit\u2019s research agenda for investigating potential adverse events associated with anthrax vaccine adsorbed","volume":"16","author":"Payne","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2307\/2686093","article-title":"Bayesian data mining in large frequency tables with an application to the FDA Spontaneous Reporting System","volume":"53","author":"DuMouchel","year":"1999","journal-title":"Am Stat"},{"key":"10.1016\/j.vaccine.2008.10.044_bib18","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1002\/pds.1107","article-title":"Comparing data mining methods on the VAERS database","volume":"14","author":"Banks","year":"2005","journal-title":"Pharmacoepidemiol Drug Saf"},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.044_bib19","doi-asserted-by":"crossref","first-page":"677","DOI":"10.2165\/00002018-200831080-00003","article-title":"Effects of stratification on data mining in the Vaccine Adverse Event Reporting System (VAERS)","volume":"31","author":"Woo","year":"2008","journal-title":"Drug Saf"},{"key":"10.1016\/j.vaccine.2008.10.044_bib20","doi-asserted-by":"crossref","first-page":"4627","DOI":"10.1016\/S0264-410X(01)00237-7","article-title":"Data mining in the US Vaccine Adverse Event Reporting System (VAERS): early detection of intussusception and other events after rotavirus vaccination","volume":"19","author":"Niu","year":"2001","journal-title":"Vaccine"},{"issue":"14","key":"10.1016\/j.vaccine.2008.10.044_bib21","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1016\/j.vaccine.2005.10.049","article-title":"Adverse events after hepatitis AB combination vaccine","volume":"24","author":"Woo","year":"2006","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.044_bib22","unstructured":"Niu MT, Salive ME, Ellenberg SS. Post-marketing surveillance for adverse events after vaccination: the national Vaccine Adverse Event Reporting System (VAERS). A MEDWATCH Continuing Education Article; 1998."},{"key":"10.1016\/j.vaccine.2008.10.044_bib23","unstructured":"21CFR600.80 (Code of Federal Regulations, Title 21, Part 600, Sec. 600.80) Postmarketing reporting of adverse experiences."},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.044_bib24","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/jama.280.11.981","article-title":"Chronic multisymptom illness affecting Air Force veterans of the Gulf War","volume":"280","author":"Fukuda","year":"1998","journal-title":"J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib25","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S0190-9622(03)00407-9","article-title":"Oral pemphigus vulgaris after anthrax vaccine administration: association or coincidence?","volume":"50","author":"Muellenhoff","year":"2004","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/j.vaccine.2008.10.044_bib26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/S1081-1206(10)61379-8","article-title":"New-onset rheumatoid arthritis after anthrax vaccination","volume":"97","author":"Vasudev","year":"2006","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib27","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S0736-4679(03)00201-4","article-title":"Lymphocytic vasculitis associated with the anthrax vaccine: case report and review of anthrax vaccination","volume":"25","author":"Muniz","year":"2003","journal-title":"J Emerg Med"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib28","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0161-6420(01)00844-2","article-title":"Optic neuritis after anthrax vaccination","volume":"109","author":"Kerrison","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib29","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1001\/archneur.63.6.871","article-title":"Anthrax vaccination and risk of Optic Neuritis in the United States military, 1998\u20132003","volume":"63","author":"Payne","year":"2006","journal-title":"Arch Neurol"},{"issue":"11","key":"10.1016\/j.vaccine.2008.10.044_bib30","first-page":"2181","article-title":"Polyarteritis nodosa reports to the Vaccine Adverse Event Reporting System (VAERS): implications for assessment of suspected vaccine-provoked vasculitis","volume":"31","author":"Begier","year":"2004","journal-title":"J Rheumatol"},{"issue":"12 Suppl.","key":"10.1016\/j.vaccine.2008.10.044_bib31","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1093\/milmed\/166.suppl_2.35","article-title":"The Psychosocial aspect of the anthrax vaccine: \u201cThe Dover Experience\u201d","volume":"166","author":"Holmstedt-Mark","year":"2001","journal-title":"Mil Med"},{"key":"10.1016\/j.vaccine.2008.10.044_bib32","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1016\/S0264-410X(01)00462-5","article-title":"Anthrax vaccine: immunogenicity and safety of a dose-reduction, route-change comparison study in humans","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.044_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1002\/pds.1359","article-title":"Short-term reactogenicity and gender effect of anthrax vaccine: analysis of a 1967\u20131972 study and review of the 1955\u20132005 medical literature","volume":"16","author":"McNeil","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.vaccine.2008.10.044_bib34","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1016\/S0264-410X(02)00172-X","article-title":"Aluminum-containing vaccine associated gender adverse events: role of route of administration and gender","volume":"20","author":"Pittman","year":"2002","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2008.10.044_bib35","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000110815","article-title":"Follow-up study on amyotrophic lateral sclerosis in Rochester, Minn., 1925 through 1984.","volume":"5","author":"Yoshida","year":"1986","journal-title":"Neuroepidemiology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib36","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1212\/WNL.30.5.463","article-title":"ALS in Rochester, Minnesota, 1925\u20131977","volume":"30","author":"Juergens","year":"1980","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1136\/jnnp.2007.117788","article-title":"Epidemiology and clinical features of amyotrophic lateral sclerosis in Ireland between 1995 and 2004","volume":"79","author":"O\u2019Toole","year":"2008","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.vaccine.2008.10.044_bib38","first-page":"281","article-title":"Epidemiology of amyotrophic lateral sclerosis","volume":"36","author":"Kurtzke","year":"1982","journal-title":"Adv Neurol"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.044_bib39","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1212\/01.WNL.0000069922.32557.CA","article-title":"Occurrence of amyotrophic lateral sclerosis among Gulf War veterans","volume":"61","author":"Horner","year":"2003","journal-title":"Neurology"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.044_bib40","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1212\/WNL.61.6.750","article-title":"Excess incidence of ALS in young Gulf War veterans","volume":"61","author":"Haley","year":"2003","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib41","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1212\/01.WNL.0000148649.17706.D9","article-title":"Prospective study of military service and mortality from ALS","volume":"64","author":"Weisskopf","year":"2005","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib42","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1212\/01.WNL.0000150535.90358.2D","article-title":"ALS and military service","volume":"64","author":"Beghi","year":"2005","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib43","first-page":"208","article-title":"Survival of 793 patients with amyotrophic lateral sclerosis diagnosed over a 28-year period","volume":"5","author":"Testa","year":"2004","journal-title":"ALS"},{"key":"10.1016\/j.vaccine.2008.10.044_bib44","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1016\/S0140-6736(03)14802-7","article-title":"Vaccination and autoimmune disease: what is the evidence?","volume":"362","author":"Wraith","year":"2003","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.044_bib45","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/oxfordjournals.aje.a112795","article-title":"Guillain-Barre syndrome following vaccination in the National Influenza Immunization Program, United States 1976\u20131977","volume":"110","author":"Schonberger","year":"1979","journal-title":"Am J Epidemiol"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.044_bib46","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1542\/peds.97.5.738","article-title":"Recurrent thrombocytopenic purpura after repeated Measles-Mumps-Rubella vaccination","volume":"97","author":"Miron","year":"1996","journal-title":"Pediatrics"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib47","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1097\/00006454-199601000-00020","article-title":"Thrombocytopenia after immunization with measles vaccines: review of the Vaccine Adverse Events Reporting System (1990 to 1994)","volume":"15","author":"Beeler","year":"1996","journal-title":"Pediatr Infect Dis J"},{"issue":"10","key":"10.1016\/j.vaccine.2008.10.044_bib48","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/j.vaccine.2006.10.054","article-title":"Vaccination associated thrombocytopenic purpura in children","volume":"25","author":"Rajantie","year":"2007","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib49","doi-asserted-by":"crossref","first-page":"e687","DOI":"10.1542\/peds.2007-1578","article-title":"Risk of immune thrombocytopenic purpura after measles-mumps-rubella immunization in children","volume":"121","author":"France","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.10.044_bib50","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1046\/j.1365-2125.2003.01790.x","article-title":"MMR vaccine and idiopathic thrombocytopaenic purpura","volume":"55","author":"Black","year":"2003","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1006\/clin.1997.4412","article-title":"Epidemiology and estimated population burden of selected autoimmune diseases in the United States","volume":"84","author":"Jacobson","year":"1997","journal-title":"Clin Immunol Immunopath"},{"key":"10.1016\/j.vaccine.2008.10.044_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","article-title":"Epidemiology of autoimmune diseases in Denmark","volume":"29","author":"Eaton","year":"2007","journal-title":"J Autoimmunity"},{"issue":"4","key":"10.1016\/j.vaccine.2008.10.044_bib53","first-page":"427","article-title":"Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States","volume":"16","author":"Lawrence","year":"1989","journal-title":"J Rheumatol"},{"key":"10.1016\/j.vaccine.2008.10.044_bib54","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.aje.a112878","article-title":"The Epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality","volume":"111","author":"Linos","year":"1980","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.vaccine.2008.10.044_bib55","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1093\/oxfordjournals.epirev.a036058","article-title":"Epidemiology of rheumatoid arthritis: update","volume":"12","author":"Hochberg","year":"1990","journal-title":"Epidemiologic Rev"},{"issue":"3","key":"10.1016\/j.vaccine.2008.10.044_bib56","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.semarthrit.2006.08.006","article-title":"Incidence and prevalence of rheumatoid arthritis, based on the 1987 American College of Rheumatology criteria: a systematic review","volume":"36","author":"Alamanos","year":"2006","journal-title":"Sem Arthritis Rheumatism"},{"key":"10.1016\/j.vaccine.2008.10.044_bib57","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1212\/WNL.32.11.1207","article-title":"The current neurologic burden of illness and injury in the United States","volume":"32","author":"Kurtzke","year":"1982","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib58","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1212\/WNL.31.8.966","article-title":"Acute transverse myelitis: incidence and etiologic considerations","volume":"31","author":"Berman","year":"1981","journal-title":"Neurology"},{"key":"10.1016\/j.vaccine.2008.10.044_bib59","doi-asserted-by":"crossref","unstructured":"Transverse Myelitis Consortium Working Group. Proposed diagnostic criteria and nosology of acute transverse myelitis. Neurology 2002;59(2):499\u2013505.","DOI":"10.1212\/WNL.59.4.499"},{"issue":"5","key":"10.1016\/j.vaccine.2008.10.044_bib60","first-page":"1247","article-title":"The Epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982\u20131991","volume":"27","author":"Shbeeb","year":"2000","journal-title":"J Rheumatol"},{"issue":"Suppl. 2","key":"10.1016\/j.vaccine.2008.10.044_bib61","doi-asserted-by":"crossref","first-page":"ii14","DOI":"10.1136\/ard.2004.032482","article-title":"Psoriatic arthritis: epidemiology, clinical features, course, and outcome","volume":"64","author":"Gladman","year":"2005","journal-title":"Ann Rheumat Dis"},{"issue":"1","key":"10.1016\/j.vaccine.2008.10.044_bib62","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1586\/17469872.1.1.63","article-title":"The epidemiology of psoriasis","volume":"1","author":"Neimann","year":"2006","journal-title":"Expert Rev Dermatol"},{"issue":"6","key":"10.1016\/j.vaccine.2008.10.044_bib63","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.1542\/peds.107.6.e97","article-title":"Intussusception among recipients of rotavirus vaccine: reports to the Vaccine Adverse Event Reporting System","volume":"107","author":"Zanardi","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/j.vaccine.2008.10.044_bib64","unstructured":"Centers for Disease Control and Prevention. Intussusception among recipients of rotavirus vaccine\u2014United States, 1998\u20131999. Morb Mort Wkly Rep 1999;48(27)577\u201381."},{"key":"10.1016\/j.vaccine.2008.10.044_bib65","unstructured":"Centers for Disease Control and Prevention. Suspension of rotavirus vaccine after reports of intussusception\u2014United States, 1999. Morb Mort Wkly Rep 2004;53(34):786\u20139."},{"issue":"8","key":"10.1016\/j.vaccine.2008.10.044_bib66","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJM200102223440804","article-title":"Intussusception among infants given an oral rotavirus vaccine","volume":"344","author":"Murphy","year":"2001","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.vaccine.2008.10.044_bib67","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1521\/suli.2006.36.2.182","article-title":"Strengthening the validity of population-based suicide rate comparisons: an illustration using U.S. military and civilian data","volume":"36","author":"Eaton","year":"2006","journal-title":"Suicide Life Threat Behav"},{"key":"10.1016\/j.vaccine.2008.10.044_bib68","series-title":"42nd National Immunization Conference","article-title":"Update from the Vaccine Analytic Unit (VAC): a unique post marketing vaccine safety research infrastructure using the Defense Medical Surveillance System (DMSS).","author":"McNeil","year":"2008"},{"key":"10.1016\/j.vaccine.2008.10.044_bib69","series-title":"42nd National Immunization Conference","article-title":"Anthrax vaccine adsorbed and risk of idiopathic atrial fibrillation in the United States military, 1998\u20132005.","author":"Davila","year":"2008"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X08014151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T20:18:32Z","timestamp":1684613912000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X08014151"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,1]]},"references-count":69,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,1]]}},"alternative-id":["S0264410X08014151"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2008.10.044","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2009,1]]}}}